Last update 04 Nov 2024

Isosorbide Mononitrate

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
5-ISM, IS 5-MN, IS-5MN
+ [73]
Target-
Mechanism
Nitric oxide donors
Originator Organization
Drug Highest PhaseApproved
First Approval Date
US (30 Dec 1991),
Regulation-
Login to view timeline

Structure

Molecular FormulaC6H9NO6
InChIKeyYWXYYJSYQOXTPL-SLPGGIOYSA-N
CAS Registry16051-77-7

External Link

R&D Status

Approved
10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
Heart Failure
CN
01 Jan 1993
Angina Pectoris
US
30 Dec 1991
Developing
10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Angina, StablePhase 3
BR
01 Jul 2014
Coronary Artery DiseasePhase 1
CN
-10 Oct 2013
Myocardial InfarctionPhase 1
CN
-10 Oct 2013
VasospasmPhase 1
CN
-10 Oct 2013
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 2
9
(Isosorbide Mononitrate)
uwsxofccfu(nsnxkldwta) = dqanfnhbsc cffogkgiyo (zsdcgfzdbf, kpezfjqffm - ndlzltphtb)
-
03 Aug 2022
Placebo oral tablet
(Placebo)
uwsxofccfu(nsnxkldwta) = dgulyhgwpp cffogkgiyo (zsdcgfzdbf, apvkcnzoam - bljnvvpfay)
Phase 2
8
(ISMN Only)
epcyyhnoad(civxdcohet) = zqrtyhhtyc ezwnoaeezz (jujbfjmdif, sbncftxanv - fqzhpixgta)
-
13 Aug 2020
Vitamin C+ISMN
(ISMN AND Vitamin C)
epcyyhnoad(civxdcohet) = iwlsuiirie ezwnoaeezz (jujbfjmdif, kajranjtuf - vilfbnjvfh)
Phase 2
110
(Isosorbide Mononitrate Crossover to Placebo)
czivcaezdu(dfxndcixgy) = zihzmqukkl pyxgtxiuof (kdmpyaziup, lllwouqeqy - xcalgwitvz)
-
28 Nov 2016
(Placebo Crossover to Isosorbide Mononitrate)
czivcaezdu(dfxndcixgy) = aedopkrtmg pyxgtxiuof (kdmpyaziup, anobrlzulv - bcetgewued)
Phase 2
110
(nfugnwzitn) = ztbozuhuup rwecbrfiaj (pcwkbnddzn, -780 to 17)
Negative
10 Dec 2015
Placebo
-
Not Applicable
60
jmwnwelqsc(ubvuwsmxdv) = pjhlyyluvc tzzhhcbcdw (dcszgeldam )
Negative
01 Nov 2013
Placebo
jmwnwelqsc(ubvuwsmxdv) = erohsnbake tzzhhcbcdw (dcszgeldam )
Not Applicable
-
-
zlpdqtgtzr(hfrvrasslf): mean difference = -1.6 (95% CI, -5.1 to 1.9), P-Value = 0.37
Positive
01 Aug 2009
Placebo
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free